101 Therapeutics
Tel Aviv · Founded 2020
About 101 Therapeutics
101 Therapeutics is a Phase II pharmaceutical company on a mission to cure infectious diseases by targeting the pathology not the the pathogen. After a successful Phase I safety trial, 101 Therapeutics is conducting a Phase II efficacy trials for its targeted COVID-19 therapy.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: https://101therapeutics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/101-therapeutics-10 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.